"Designing Growth Strategies is in our DNA"

Prescription Drugs Market Size, Share & Industry Analysis, By Product Type (Generics, Orphan, and Other Prescription Drugs), By Therapy (Oncology, Central Nervous System, Vaccines, Immunosuppressants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI102709

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 7.1% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Product Type

  • Generics
  • Orphan
  • Other Prescription Drugs

By Application

  • Oncology
  • Central Nervous System
  • Vaccines
  • Immunosuppressants
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Others

By Geography

  • North America (By Product Type, By Application, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Diabetes Type, By Distribution Channel, and By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, By Distribution Channel, and By Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, By Distribution Channel, and By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, By Distribution Channel, and By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • 2019-2032
  • 2023
  • 2019-2022
  • 140
Consulting Services
    How will you benefit from our consulting services ?